Search and Filter
Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
HVTN at the 24th International AIDS Conference in Montreal

HVTN at the 24th International AIDS Conference in Montreal

HVTN researchers and faith leaders will address HIV and SARS-CoV-2, neutralizing antibodies, future directions for research, lessons from COVID-19 community engagement, overcoming HIV stigma and discrimination, and more
News Releases - July 28, 2022
CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

Response comparable to mRNA vaccines and if authorized, could help bolster global vaccine supplies
News Releases - June 28, 2022
Antibody Mediated Prevention (AMP) Trials Data Published by the New England Journal of Medicine

Antibody Mediated Prevention (AMP) Trials Data Published by the New England Journal of Medicine

Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains
News Releases - March 17, 2021